ZA200904660B - Treatment of IL-1-Beta related diseases - Google Patents
Treatment of IL-1-Beta related diseasesInfo
- Publication number
- ZA200904660B ZA200904660B ZA200904660A ZA200904660A ZA200904660B ZA 200904660 B ZA200904660 B ZA 200904660B ZA 200904660 A ZA200904660 A ZA 200904660A ZA 200904660 A ZA200904660 A ZA 200904660A ZA 200904660 B ZA200904660 B ZA 200904660B
- Authority
- ZA
- South Africa
- Prior art keywords
- treatment
- related diseases
- beta related
- beta
- diseases
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87104606P | 2006-12-20 | 2006-12-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200904660B true ZA200904660B (en) | 2010-04-28 |
Family
ID=41495869
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200904660A ZA200904660B (en) | 2006-12-20 | 2009-07-02 | Treatment of IL-1-Beta related diseases |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN101616690B (en) |
CA (1) | CA2839162A1 (en) |
ZA (1) | ZA200904660B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2992009B1 (en) * | 2013-05-01 | 2020-06-24 | Ionis Pharmaceuticals, Inc. | Compositions and methods for modulating apolipoprotein (a) expression |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1423432A4 (en) * | 2001-07-26 | 2006-01-11 | Lilly Co Eli | Interleukin-1 beta antibodies |
ES2827247T3 (en) * | 2005-06-21 | 2021-05-20 | Xoma Us Llc | Antibodies and fragments thereof that bind IL-1beta |
-
2007
- 2007-12-20 CA CA2839162A patent/CA2839162A1/en not_active Abandoned
- 2007-12-20 CN CN200780051536.4A patent/CN101616690B/en not_active Expired - Fee Related
-
2009
- 2009-07-02 ZA ZA200904660A patent/ZA200904660B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101616690A (en) | 2009-12-30 |
CN101616690B (en) | 2015-11-25 |
CA2839162A1 (en) | 2008-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1131047A1 (en) | Treatment of inflammatory diseases | |
PT2044111E (en) | Targeting complement factor h for treatment of diseases | |
EP2004204A4 (en) | Treatment of neurodegenerative diseases | |
ZA200707591B (en) | Dihyrothienopyrimidines for the treatment of inflammatory diseases | |
GB0610867D0 (en) | Treatment of pain | |
ZA200808178B (en) | Imidazolothiazole compounds for the treatment of disease | |
EP2182983A4 (en) | Treatment of amyloidogenic diseases | |
EP2021352A4 (en) | Treatment of protein misfolding | |
IL193748A0 (en) | Treatment of pain | |
SI2056863T1 (en) | Treatment of ocular diseases | |
PL2056842T3 (en) | Modified-galactosyl ceramide for the treatment of cancerous diseases | |
HK1148684A1 (en) | Treatment of prion protein related diseases | |
EP1962869A4 (en) | Treatment of respiratory diseases | |
ZA200806808B (en) | Treatment of stressed patients | |
GB0610183D0 (en) | Treatment of neurodegenerative diseases | |
EP2026822A4 (en) | Topical treatment for diseases of eye surface | |
EP2210621A4 (en) | Composition for treatment of joint disease | |
GB2458868A8 (en) | Treatment of protein aggregation diseases | |
GB0610868D0 (en) | Treatment of pain | |
IL188894A0 (en) | Compounds for treatment of lipase-mediated diseases | |
GB0623740D0 (en) | Treatment of disease | |
GB0622136D0 (en) | Treatment of gastrointestinal diseases | |
ZA200904660B (en) | Treatment of IL-1-Beta related diseases | |
GB0616450D0 (en) | Treatment of pain | |
GB0622137D0 (en) | Treatment of gastrointestinal diseases |